PMC:7205724 / 9990-11458
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 314 | 32-40 | Species | denotes | patients | Tax:9606 |
| 315 | 56-64 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 318 | 99-107 | Species | denotes | patients | Tax:9606 |
| 319 | 123-131 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 329 | 346-350 | Species | denotes | H1N1 | Tax:114727 |
| 330 | 408-419 | Species | denotes | Ebola virus | Tax:205488 |
| 331 | 458-466 | Species | denotes | MERS-CoV | Tax:1335626 |
| 332 | 544-552 | Species | denotes | patients | Tax:9606 |
| 333 | 558-566 | Species | denotes | SARS-CoV | Tax:694009 |
| 334 | 334-343 | Species | denotes | influenza | Tax:11309 |
| 335 | 571-580 | Species | denotes | influenza | Tax:11309 |
| 336 | 366-381 | Disease | denotes | virus infection | MESH:D001102 |
| 337 | 531-540 | Disease | denotes | mortality | MESH:D003643 |
| 342 | 663-671 | Species | denotes | patients | Tax:9606 |
| 343 | 706-714 | Species | denotes | patients | Tax:9606 |
| 344 | 687-695 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 345 | 727-735 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 353 | 1128-1131 | Gene | denotes | CRP | Gene:1401 |
| 354 | 970-978 | Species | denotes | patients | Tax:9606 |
| 355 | 1054-1062 | Species | denotes | patients | Tax:9606 |
| 356 | 1193-1201 | Species | denotes | patients | Tax:9606 |
| 357 | 1211-1220 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 358 | 1283-1292 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 359 | 991-999 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T70 | 20-26 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T71 | 87-93 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
| T72 | 230-236 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T73 | 604-610 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T74 | 651-657 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T75 | 819-825 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T76 | 839-847 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T77 | 1093-1103 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
| T78 | 1171-1177 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T79 | 1221-1224 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T80 | 1269-1275 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T81 | 1355-1361 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T82 | 1461-1467 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T56 | 56-64 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T57 | 123-131 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T58 | 334-350 | Disease | denotes | influenza A H1N1 | http://purl.obolibrary.org/obo/MONDO_0005460 |
| T59 | 334-343 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T60 | 366-381 | Disease | denotes | virus infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T61 | 372-381 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T62 | 408-413 | Disease | denotes | Ebola | http://purl.obolibrary.org/obo/MONDO_0005737 |
| T63 | 558-566 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T64 | 571-580 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T65 | 687-695 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T66 | 727-735 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T67 | 991-999 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T68 | 1211-1215 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T69 | 1283-1287 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T103 | 20-26 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T104 | 87-93 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
| T105 | 169-170 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T106 | 230-236 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T107 | 344-345 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T108 | 366-371 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T109 | 414-419 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T110 | 513-514 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T111 | 604-610 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T112 | 651-657 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T113 | 736-737 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T114 | 751-753 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T115 | 764-767 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T116 | 819-825 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T117 | 966-969 | http://purl.obolibrary.org/obo/CLO_0050884 | denotes | ten |
| T118 | 1050-1053 | http://purl.obolibrary.org/obo/CLO_0050884 | denotes | ten |
| T119 | 1114-1115 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T120 | 1171-1177 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T121 | 1269-1275 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T122 | 1355-1361 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T123 | 1461-1467 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T121 | 895-912 | Chemical | denotes | anti-viral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T6 | 768-780 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | investigated | http://purl.bioontology.org/ontology/MEDDRA/10062026 |
| T7 | 1093-1109 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | lymphocyte count | http://purl.bioontology.org/ontology/MEDDRA/10025251 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T46 | 183-190 | http://purl.obolibrary.org/obo/BFO_0000182 | denotes | history |
| T47 | 366-371 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T48 | 372-381 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
| T49 | 414-419 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T82 | 1221-1224 | Chemical | denotes | RNA | http://purl.obolibrary.org/obo/CHEBI_33697 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T73 | 56-64 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T74 | 123-131 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T75 | 159-168 | Species | denotes | 2019-nCoV | NCBItxid:2697049 |
| T76 | 346-350 | Species | denotes | H1N1 | NCBItxid:114727 |
| T77 | 408-419 | Species | denotes | Ebola virus | NCBItxid:1570291 |
| T78 | 458-466 | Species | denotes | MERS-CoV | NCBItxid:1335626 |
| T79 | 558-566 | Species | denotes | SARS-CoV | NCBItxid:694009 |
| T80 | 687-695 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T81 | 727-735 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T82 | 991-999 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T83 | 1211-1220 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
| T84 | 1283-1292 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T84 | 0-64 | Sentence | denotes | 4.1.1 Convalescent plasma from patients recovered from COVID-19 |
| T85 | 66-86 | Sentence | denotes | 4.1.1.1 Hypothesis: |
| T86 | 87-168 | Sentence | denotes | Plasma from patients recovered from COVID-19 contain antibodies against 2019-nCoV |
| T87 | 169-284 | Sentence | denotes | A look at the history of viral outbreaks offers convalescent plasma as the only remedy to avoid further fatalities. |
| T88 | 285-479 | Sentence | denotes | The most recent examples include the pandemic of influenza A H1N1 (H1N1pdm09) in virus infection 2009, the Western African Ebola virus epidemic in 2014, and the outbreak of MERS-CoV in 2015 [9]. |
| T89 | 480-616 | Sentence | denotes | Meta-analysis studies have shown a reduced risk of mortality in patients with SARS-CoV and influenza receiving convalescent plasma [10]. |
| T90 | 618-637 | Sentence | denotes | 4.1.1.2 Rationale: |
| T91 | 638-735 | Sentence | denotes | Convalescent plasma from patients recovered from COVID-19 can treat patients with severe COVID-19 |
| T92 | 736-1000 | Sentence | denotes | A pilot study [11] recently has investigated the safety and effect of convalescent plasma that contain antibody levels higher than 1:640 combined with regular anti-viral agents and standard supportive care on clinical outcomes of ten patients with severe COVID-19. |
| T93 | 1001-1132 | Sentence | denotes | The study showed clinical improvement of all the ten patients accompanied by an increase in lymphocyte count and a decrease in CRP. |
| T94 | 1133-1302 | Sentence | denotes | Following transfusion of convalescent plasma, all the seven patients who were SARS-CoV2 RNA positive before transfusion of convalescent plasma turned SARS-CoV2 negative. |
| T95 | 1303-1468 | Sentence | denotes | There were no control groups receiving convalescent plasma alone or standard therapy without convalescent therapy to evaluate the main effect of convalescent plasma. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 314 | 32-40 | Species | denotes | patients | Tax:9606 |
| 315 | 56-64 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 318 | 99-107 | Species | denotes | patients | Tax:9606 |
| 319 | 123-131 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 334 | 334-343 | Species | denotes | influenza | Tax:11309 |
| 329 | 346-350 | Species | denotes | H1N1 | Tax:114727 |
| 336 | 366-381 | Disease | denotes | virus infection | MESH:D001102 |
| 330 | 408-419 | Species | denotes | Ebola virus | Tax:205488 |
| 331 | 458-466 | Species | denotes | MERS-CoV | Tax:1335626 |
| 337 | 531-540 | Disease | denotes | mortality | MESH:D003643 |
| 332 | 544-552 | Species | denotes | patients | Tax:9606 |
| 333 | 558-566 | Species | denotes | SARS-CoV | Tax:694009 |
| 335 | 571-580 | Species | denotes | influenza | Tax:11309 |
| 342 | 663-671 | Species | denotes | patients | Tax:9606 |
| 344 | 687-695 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 343 | 706-714 | Species | denotes | patients | Tax:9606 |
| 345 | 727-735 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 354 | 970-978 | Species | denotes | patients | Tax:9606 |
| 359 | 991-999 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 355 | 1054-1062 | Species | denotes | patients | Tax:9606 |
| 353 | 1128-1131 | Gene | denotes | CRP | Gene:1401 |
| 356 | 1193-1201 | Species | denotes | patients | Tax:9606 |
| 357 | 1211-1220 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 358 | 1283-1292 | Species | denotes | SARS-CoV2 | Tax:2697049 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T1222 | 1128-1131 | Protein | denotes | CRP | https://www.uniprot.org/uniprot/Q5U0J2|https://www.uniprot.org/uniprot/Q07203|https://www.uniprot.org/uniprot/Q01687|https://www.uniprot.org/uniprot/P97315|https://www.uniprot.org/uniprot/P67967|https://www.uniprot.org/uniprot/P67966|https://www.uniprot.org/uniprot/P47875|https://www.uniprot.org/uniprot/P32965|https://www.uniprot.org/uniprot/P21291|https://www.uniprot.org/uniprot/P08462|https://www.uniprot.org/uniprot/A8K268 |
LitCovid-sample-Enju
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T34096 | 0-5 | CD | denotes | 4.1.1 |
| T81207 | 7-19 | JJ | denotes | Convalescent |
| T7654 | 20-26 | NN | denotes | plasma |
| T71050 | 27-31 | IN | denotes | from |
| T25890 | 32-40 | NNS | denotes | patients |
| T44174 | 41-50 | VBN | denotes | recovered |
| T26910 | 51-55 | IN | denotes | from |
| T41378 | 56-64 | NN | denotes | COVID-19 |
| T88463 | 66-73 | CD | denotes | 4.1.1.1 |
| T5371 | 75-85 | NN | denotes | Hypothesis |
| T65084 | 85-86 | -COLON- | denotes | : |
| T11805 | 87-93 | NN | denotes | Plasma |
| T86158 | 94-98 | IN | denotes | from |
| T7828 | 99-107 | NNS | denotes | patients |
| T20215 | 108-117 | VBN | denotes | recovered |
| T19523 | 118-122 | IN | denotes | from |
| T35336 | 123-131 | NN | denotes | COVID-19 |
| T99442 | 132-139 | VBP | denotes | contain |
| T6188 | 140-150 | NNS | denotes | antibodies |
| T80510 | 151-158 | IN | denotes | against |
| T57397 | 159-168 | NN | denotes | 2019-nCoV |
| T57607 | 169-170 | DT | denotes | A |
| T47460 | 171-175 | NN | denotes | look |
| T44003 | 176-178 | IN | denotes | at |
| T20122 | 179-182 | DT | denotes | the |
| T89678 | 183-190 | NN | denotes | history |
| T33850 | 191-193 | IN | denotes | of |
| T21640 | 194-199 | JJ | denotes | viral |
| T53029 | 200-209 | NNS | denotes | outbreaks |
| T73113 | 210-216 | VBZ | denotes | offers |
| T71269 | 217-229 | JJ | denotes | convalescent |
| T26722 | 230-236 | NN | denotes | plasma |
| T32817 | 237-239 | IN | denotes | as |
| T73367 | 240-243 | DT | denotes | the |
| T23573 | 244-248 | JJ | denotes | only |
| T80270 | 249-255 | NN | denotes | remedy |
| T50380 | 256-258 | TO | denotes | to |
| T14621 | 259-264 | VB | denotes | avoid |
| T15138 | 265-272 | JJ | denotes | further |
| T77639 | 273-283 | NNS | denotes | fatalities |
| T94916 | 285-288 | DT | denotes | The |
| T85352 | 289-293 | RBS | denotes | most |
| T26901 | 294-300 | JJ | denotes | recent |
| T70143 | 301-309 | NNS | denotes | examples |
| T49434 | 310-317 | VBP | denotes | include |
| T54973 | 318-321 | DT | denotes | the |
| T39553 | 322-330 | NN | denotes | pandemic |
| T56433 | 331-333 | IN | denotes | of |
| T99958 | 334-343 | NN | denotes | influenza |
| T27857 | 344-345 | NN | denotes | A |
| T52981 | 346-350 | NN | denotes | H1N1 |
| T85532 | 351-352 | -LRB- | denotes | ( |
| T70555 | 352-361 | NN | denotes | H1N1pdm09 |
| T58026 | 361-362 | -RRB- | denotes | ) |
| T49738 | 363-365 | IN | denotes | in |
| T7553 | 366-371 | NN | denotes | virus |
| T41345 | 372-381 | NN | denotes | infection |
| T46256 | 382-386 | CD | denotes | 2009 |
| T28857 | 386-387 | -COMMA- | denotes | , |
| T13934 | 388-391 | DT | denotes | the |
| T20739 | 392-399 | NNP | denotes | Western |
| T80018 | 400-407 | NNP | denotes | African |
| T70659 | 408-413 | NNP | denotes | Ebola |
| T34284 | 414-419 | NN | denotes | virus |
| T92495 | 420-428 | JJ | denotes | epidemic |
| T36003 | 429-431 | IN | denotes | in |
| T12982 | 432-436 | CD | denotes | 2014 |
| T49803 | 436-437 | -COMMA- | denotes | , |
| T90021 | 438-441 | CC | denotes | and |
| T16664 | 442-445 | DT | denotes | the |
| T58899 | 446-454 | NN | denotes | outbreak |
| T11963 | 455-457 | IN | denotes | of |
| T71906 | 458-466 | NN | denotes | MERS-CoV |
| T74174 | 467-469 | IN | denotes | in |
| T70278 | 470-474 | CD | denotes | 2015 |
| T44828 | 475-476 | -LRB- | denotes | [ |
| T58846 | 476-477 | CD | denotes | 9 |
| T98769 | 477-478 | -RRB- | denotes | ] |
| T44041 | 480-493 | NN | denotes | Meta-analysis |
| T92755 | 494-501 | NNS | denotes | studies |
| T83388 | 502-506 | VBP | denotes | have |
| T75238 | 507-512 | VBN | denotes | shown |
| T72067 | 513-514 | DT | denotes | a |
| T19254 | 515-522 | VBN | denotes | reduced |
| T86955 | 523-527 | NN | denotes | risk |
| T79896 | 528-530 | IN | denotes | of |
| T13682 | 531-540 | NN | denotes | mortality |
| T55812 | 541-543 | IN | denotes | in |
| T18322 | 544-552 | NNS | denotes | patients |
| T80297 | 553-557 | IN | denotes | with |
| T10571 | 558-566 | NN | denotes | SARS-CoV |
| T28781 | 567-570 | CC | denotes | and |
| T12582 | 571-580 | NN | denotes | influenza |
| T82834 | 581-590 | VBG | denotes | receiving |
| T84690 | 591-603 | JJ | denotes | convalescent |
| T47738 | 604-610 | NN | denotes | plasma |
| T87902 | 611-612 | -LRB- | denotes | [ |
| T15127 | 612-614 | CD | denotes | 10 |
| T21677 | 614-615 | -RRB- | denotes | ] |
| T51845 | 618-625 | CD | denotes | 4.1.1.2 |
| T81264 | 627-636 | NNP | denotes | Rationale |
| T56248 | 636-637 | -COLON- | denotes | : |
| T77485 | 638-650 | JJ | denotes | Convalescent |
| T80710 | 651-657 | NN | denotes | plasma |
| T37520 | 658-662 | IN | denotes | from |
| T57657 | 663-671 | NNS | denotes | patients |
| T22774 | 672-681 | VBN | denotes | recovered |
| T85435 | 682-686 | IN | denotes | from |
| T50571 | 687-695 | NN | denotes | COVID-19 |
| T48141 | 696-699 | MD | denotes | can |
| T93212 | 700-705 | VB | denotes | treat |
| T48287 | 706-714 | NNS | denotes | patients |
| T91679 | 715-719 | IN | denotes | with |
| T80666 | 720-726 | JJ | denotes | severe |
| T17217 | 727-735 | NN | denotes | COVID-19 |
| T94687 | 736-737 | DT | denotes | A |
| T22655 | 738-743 | NN | denotes | pilot |
| T19573 | 744-749 | NN | denotes | study |
| T23972 | 750-751 | -LRB- | denotes | [ |
| T55337 | 751-753 | CD | denotes | 11 |
| T96728 | 753-754 | -RRB- | denotes | ] |
| T92410 | 755-763 | RB | denotes | recently |
| T26265 | 764-767 | VBZ | denotes | has |
| T35997 | 768-780 | VBN | denotes | investigated |
| T92380 | 781-784 | DT | denotes | the |
| T38590 | 785-791 | NN | denotes | safety |
| T37156 | 792-795 | CC | denotes | and |
| T24661 | 796-802 | NN | denotes | effect |
| T94632 | 803-805 | IN | denotes | of |
| T56352 | 806-818 | JJ | denotes | convalescent |
| T65134 | 819-825 | NN | denotes | plasma |
| T64844 | 826-830 | WDT | denotes | that |
| T95987 | 831-838 | VBP | denotes | contain |
| T86655 | 839-847 | NN | denotes | antibody |
| T45118 | 848-854 | NNS | denotes | levels |
| T26321 | 855-861 | JJR | denotes | higher |
| T17226 | 862-866 | IN | denotes | than |
| T2522 | 867-868 | CD | denotes | 1 |
| T48589 | 868-869 | -COLON- | denotes | : |
| T90182 | 869-872 | CD | denotes | 640 |
| T89317 | 873-881 | VBN | denotes | combined |
| T28925 | 882-886 | IN | denotes | with |
| T68950 | 887-894 | JJ | denotes | regular |
| T58621 | 895-905 | JJ | denotes | anti-viral |
| T22929 | 906-912 | NNS | denotes | agents |
| T50644 | 913-916 | CC | denotes | and |
| T63224 | 917-925 | JJ | denotes | standard |
| T22041 | 926-936 | JJ | denotes | supportive |
| T89053 | 937-941 | NN | denotes | care |
| T94835 | 942-944 | IN | denotes | on |
| T20257 | 945-953 | JJ | denotes | clinical |
| T49329 | 954-962 | NNS | denotes | outcomes |
| T91601 | 963-965 | IN | denotes | of |
| T6238 | 966-969 | CD | denotes | ten |
| T3048 | 970-978 | NNS | denotes | patients |
| T18696 | 979-983 | IN | denotes | with |
| T93206 | 984-990 | JJ | denotes | severe |
| T71443 | 991-999 | NN | denotes | COVID-19 |
| T46997 | 1001-1004 | DT | denotes | The |
| T7672 | 1005-1010 | NN | denotes | study |
| T83098 | 1011-1017 | VBD | denotes | showed |
| T5017 | 1018-1026 | JJ | denotes | clinical |
| T96870 | 1027-1038 | NN | denotes | improvement |
| T42442 | 1039-1041 | IN | denotes | of |
| T61149 | 1042-1045 | PDT | denotes | all |
| T89276 | 1046-1049 | DT | denotes | the |
| T53728 | 1050-1053 | CD | denotes | ten |
| T50396 | 1054-1062 | NNS | denotes | patients |
| T59179 | 1063-1074 | VBN | denotes | accompanied |
| T83510 | 1075-1077 | IN | denotes | by |
| T2183 | 1078-1080 | DT | denotes | an |
| T4240 | 1081-1089 | NN | denotes | increase |
| T18383 | 1090-1092 | IN | denotes | in |
| T99269 | 1093-1103 | NN | denotes | lymphocyte |
| T12131 | 1104-1109 | NN | denotes | count |
| T36613 | 1110-1113 | CC | denotes | and |
| T91622 | 1114-1115 | DT | denotes | a |
| T39579 | 1116-1124 | NN | denotes | decrease |
| T72559 | 1125-1127 | IN | denotes | in |
| T31686 | 1128-1131 | NN | denotes | CRP |
| T20580 | 1133-1142 | VBG | denotes | Following |
| T23341 | 1143-1154 | NN | denotes | transfusion |
| T23846 | 1155-1157 | IN | denotes | of |
| T23496 | 1158-1170 | JJ | denotes | convalescent |
| T68740 | 1171-1177 | NN | denotes | plasma |
| T74721 | 1177-1178 | -COMMA- | denotes | , |
| T3255 | 1179-1182 | PDT | denotes | all |
| T47829 | 1183-1186 | DT | denotes | the |
| T16466 | 1187-1192 | CD | denotes | seven |
| T26913 | 1193-1201 | NNS | denotes | patients |
| T47643 | 1202-1205 | WP | denotes | who |
| T10299 | 1206-1210 | VBD | denotes | were |
| T19318 | 1211-1220 | NN | denotes | SARS-CoV2 |
| T2642 | 1221-1224 | NN | denotes | RNA |
| T76428 | 1225-1233 | JJ | denotes | positive |
| T59448 | 1234-1240 | IN | denotes | before |
| T49967 | 1241-1252 | NN | denotes | transfusion |
| T2352 | 1253-1255 | IN | denotes | of |
| T3020 | 1256-1268 | JJ | denotes | convalescent |
| T57517 | 1269-1275 | NN | denotes | plasma |
| T55829 | 1276-1282 | VBD | denotes | turned |
| T39392 | 1283-1292 | NN | denotes | SARS-CoV2 |
| T26456 | 1293-1301 | JJ | denotes | negative |
| T52249 | 1303-1308 | EX | denotes | There |
| T13795 | 1309-1313 | VBD | denotes | were |
| T15563 | 1314-1316 | DT | denotes | no |
| T53693 | 1317-1324 | NN | denotes | control |
| T35357 | 1325-1331 | NNS | denotes | groups |
| T16756 | 1332-1341 | VBG | denotes | receiving |
| T53621 | 1342-1354 | JJ | denotes | convalescent |
| T81904 | 1355-1361 | NN | denotes | plasma |
| T11852 | 1362-1367 | RB | denotes | alone |
| T58859 | 1368-1370 | CC | denotes | or |
| T35171 | 1371-1379 | JJ | denotes | standard |
| T39367 | 1380-1387 | NN | denotes | therapy |
| T20306 | 1388-1395 | IN | denotes | without |
| T63670 | 1396-1408 | JJ | denotes | convalescent |
| T44856 | 1409-1416 | NN | denotes | therapy |
| T15733 | 1417-1419 | TO | denotes | to |
| T71428 | 1420-1428 | VB | denotes | evaluate |
| T29390 | 1429-1432 | DT | denotes | the |
| T54708 | 1433-1437 | JJ | denotes | main |
| T64138 | 1438-1444 | NN | denotes | effect |
| T21425 | 1445-1447 | IN | denotes | of |
| T75685 | 1448-1460 | JJ | denotes | convalescent |
| T78861 | 1461-1467 | NN | denotes | plasma |
| R32394 | T22929 | T58621 | arg1Of | agents,anti-viral |
| R12539 | T22929 | T50644 | arg1Of | agents,and |
| R32883 | T89053 | T50644 | arg2Of | care,and |
| R99734 | T89053 | T63224 | arg1Of | care,standard |
| R84751 | T89053 | T22041 | arg1Of | care,supportive |
| R58957 | T48589 | T94835 | arg1Of | :,on |
| R75573 | T49329 | T94835 | arg2Of | outcomes,on |
| R9700 | T7654 | T34096 | arg1Of | plasma,4.1.1 |
| R55934 | T7654 | T81207 | arg1Of | plasma,Convalescent |
| R34567 | T7654 | T71050 | arg1Of | plasma,from |
| R8614 | T25890 | T71050 | arg2Of | patients,from |
| R19161 | T25890 | T44174 | arg2Of | patients,recovered |
| R3402 | T44174 | T26910 | arg1Of | recovered,from |
| R78843 | T41378 | T26910 | arg2Of | COVID-19,from |
| R18397 | T5371 | T88463 | arg1Of | Hypothesis,4.1.1.1 |
| R76601 | T5371 | T65084 | arg1Of | Hypothesis,: |
| R93481 | T11805 | T86158 | arg1Of | Plasma,from |
| R26398 | T7828 | T86158 | arg2Of | patients,from |
| R4590 | T7828 | T20215 | arg2Of | patients,recovered |
| R41132 | T20215 | T19523 | arg1Of | recovered,from |
| R2213 | T35336 | T19523 | arg2Of | COVID-19,from |
| R49394 | T11805 | T99442 | arg1Of | Plasma,contain |
| R23547 | T6188 | T99442 | arg2Of | antibodies,contain |
| R94604 | T6188 | T80510 | arg1Of | antibodies,against |
| R58884 | T57397 | T80510 | arg2Of | 2019-nCoV,against |
| R25631 | T47460 | T57607 | arg1Of | look,A |
| R68452 | T47460 | T44003 | arg1Of | look,at |
| R59048 | T89678 | T44003 | arg2Of | history,at |
| R25939 | T89678 | T20122 | arg1Of | history,the |
| R52150 | T89678 | T33850 | arg1Of | history,of |
| R31752 | T53029 | T33850 | arg2Of | outbreaks,of |
| R76424 | T53029 | T21640 | arg1Of | outbreaks,viral |
| R94096 | T47460 | T73113 | arg1Of | look,offers |
| R27652 | T26722 | T73113 | arg2Of | plasma,offers |
| R64711 | T26722 | T71269 | arg1Of | plasma,convalescent |
| R42164 | T73113 | T32817 | arg1Of | offers,as |
| R26531 | T80270 | T32817 | arg2Of | remedy,as |
| R33232 | T80270 | T73367 | arg1Of | remedy,the |
| R86011 | T80270 | T23573 | arg1Of | remedy,only |
| R46142 | T14621 | T50380 | arg1Of | avoid,to |
| R87244 | T73113 | T50380 | modOf | offers,to |
| R83234 | T47460 | T14621 | arg1Of | look,avoid |
| R39441 | T77639 | T14621 | arg2Of | fatalities,avoid |
| R19535 | T77639 | T15138 | arg1Of | fatalities,further |
| R15380 | T70143 | T94916 | arg1Of | examples,The |
| R74510 | T26901 | T85352 | arg1Of | recent,most |
| R53215 | T70143 | T26901 | arg1Of | examples,recent |
| R84591 | T70143 | T49434 | arg1Of | examples,include |
| R41319 | T90021 | T49434 | arg2Of | and,include |
| R55406 | T39553 | T54973 | arg1Of | pandemic,the |
| R19973 | T39553 | T56433 | arg1Of | pandemic,of |
| R88239 | T52981 | T56433 | arg2Of | H1N1,of |
| R75498 | T52981 | T99958 | arg1Of | H1N1,influenza |
| R57082 | T52981 | T27857 | arg1Of | H1N1,A |
| R81932 | T52981 | T85532 | arg1Of | H1N1,( |
| R65037 | T70555 | T85532 | arg2Of | H1N1pdm09,( |
| R26598 | T58026 | T85532 | arg3Of | ),( |
| R39309 | T52981 | T49738 | arg1Of | H1N1,in |
| R5982 | T41345 | T49738 | arg2Of | infection,in |
| R98776 | T41345 | T7553 | arg1Of | infection,virus |
| R57317 | T41345 | T46256 | arg1Of | infection,2009 |
| R18532 | T41345 | T28857 | arg1Of | infection,"," |
| R59147 | T34284 | T28857 | arg2Of | virus,"," |
| R18564 | T34284 | T13934 | arg1Of | virus,the |
| R70515 | T70659 | T20739 | arg1Of | Ebola,Western |
| R65296 | T70659 | T80018 | arg1Of | Ebola,African |
| R96279 | T34284 | T70659 | arg1Of | virus,Ebola |
| R83132 | T34284 | T92495 | arg1Of | virus,epidemic |
| R71366 | T92495 | T36003 | arg1Of | epidemic,in |
| R78893 | T12982 | T36003 | arg2Of | 2014,in |
| R89583 | T90021 | T49803 | arg1Of | and,"," |
| R34230 | T39553 | T90021 | arg1Of | pandemic,and |
| R3169 | T58899 | T90021 | arg2Of | outbreak,and |
| R57304 | T58899 | T16664 | arg1Of | outbreak,the |
| R76318 | T58899 | T11963 | arg1Of | outbreak,of |
| R71138 | T71906 | T11963 | arg2Of | MERS-CoV,of |
| R11171 | T49434 | T74174 | arg1Of | include,in |
| R21352 | T70278 | T74174 | arg2Of | 2015,in |
| R19361 | T49434 | T44828 | arg1Of | include,[ |
| R12803 | T58846 | T44828 | arg2Of | 9,[ |
| R43811 | T98769 | T44828 | arg3Of | ],[ |
| R65283 | T92755 | T44041 | arg1Of | studies,Meta-analysis |
| R95414 | T92755 | T83388 | arg1Of | studies,have |
| R42612 | T75238 | T83388 | arg2Of | shown,have |
| R72806 | T92755 | T75238 | arg1Of | studies,shown |
| R5113 | T86955 | T75238 | arg2Of | risk,shown |
| R73986 | T86955 | T72067 | arg1Of | risk,a |
| R41187 | T86955 | T19254 | arg2Of | risk,reduced |
| R36473 | T86955 | T79896 | arg1Of | risk,of |
| R76627 | T13682 | T79896 | arg2Of | mortality,of |
| R27621 | T86955 | T55812 | arg1Of | risk,in |
| R8881 | T18322 | T55812 | arg2Of | patients,in |
| R35442 | T18322 | T80297 | arg1Of | patients,with |
| R46656 | T28781 | T80297 | arg2Of | and,with |
| R96095 | T10571 | T28781 | arg1Of | SARS-CoV,and |
| R91436 | T12582 | T28781 | arg2Of | influenza,and |
| R47598 | T18322 | T82834 | arg1Of | patients,receiving |
| R71140 | T47738 | T82834 | arg2Of | plasma,receiving |
| R67016 | T47738 | T84690 | arg1Of | plasma,convalescent |
| R88979 | T47738 | T87902 | arg1Of | plasma,[ |
| R34245 | T15127 | T87902 | arg2Of | 10,[ |
| R10750 | T21677 | T87902 | arg3Of | ],[ |
| R88677 | T81264 | T51845 | arg1Of | Rationale,4.1.1.2 |
| R9567 | T81264 | T56248 | arg1Of | Rationale,: |
| R28137 | T80710 | T77485 | arg1Of | plasma,Convalescent |
| R21152 | T80710 | T37520 | arg1Of | plasma,from |
| R54555 | T57657 | T37520 | arg2Of | patients,from |
| R72924 | T57657 | T22774 | arg2Of | patients,recovered |
| R11993 | T22774 | T85435 | arg1Of | recovered,from |
| R2179 | T50571 | T85435 | arg2Of | COVID-19,from |
| R17226 | T80710 | T48141 | arg1Of | plasma,can |
| R27403 | T93212 | T48141 | arg2Of | treat,can |
| R75667 | T80710 | T93212 | arg1Of | plasma,treat |
| R80215 | T48287 | T93212 | arg2Of | patients,treat |
| R63671 | T48287 | T91679 | arg1Of | patients,with |
| R22614 | T17217 | T91679 | arg2Of | COVID-19,with |
| R57108 | T17217 | T80666 | arg1Of | COVID-19,severe |
| R52082 | T19573 | T94687 | arg1Of | study,A |
| R65194 | T19573 | T22655 | arg1Of | study,pilot |
| R95106 | T19573 | T23972 | arg1Of | study,[ |
| R42168 | T55337 | T23972 | arg2Of | 11,[ |
| R95339 | T96728 | T23972 | arg3Of | ],[ |
| R78448 | T35997 | T92410 | arg1Of | investigated,recently |
| R65706 | T19573 | T26265 | arg1Of | study,has |
| R73941 | T35997 | T26265 | arg2Of | investigated,has |
| R20951 | T19573 | T35997 | arg1Of | study,investigated |
| R83087 | T37156 | T35997 | arg2Of | and,investigated |
| R97536 | T37156 | T92380 | arg1Of | and,the |
| R32731 | T38590 | T37156 | arg1Of | safety,and |
| R69272 | T24661 | T37156 | arg2Of | effect,and |
| R40627 | T37156 | T94632 | arg1Of | and,of |
| R73729 | T65134 | T94632 | arg2Of | plasma,of |
| R7895 | T65134 | T56352 | arg1Of | plasma,convalescent |
| R7377 | T37156 | T64844 | arg1Of | and,that |
| R67249 | T37156 | T95987 | arg1Of | and,contain |
| R70225 | T45118 | T95987 | arg2Of | levels,contain |
| R10830 | T45118 | T86655 | arg1Of | levels,antibody |
| R61261 | T45118 | T26321 | arg1Of | levels,higher |
| R50969 | T26321 | T17226 | arg1Of | higher,than |
| R4008 | T48589 | T17226 | arg2Of | :,than |
| R30054 | T2522 | T48589 | arg1Of | 1,: |
| R45762 | T90182 | T48589 | arg2Of | 640,: |
| R9970 | T48589 | T89317 | arg2Of | :,combined |
| R87348 | T89317 | T28925 | arg1Of | combined,with |
| R60332 | T50644 | T28925 | arg2Of | and,with |
| R69387 | T22929 | T68950 | arg1Of | agents,regular |
| R98484 | T49329 | T20257 | arg1Of | outcomes,clinical |
| R34116 | T49329 | T91601 | arg1Of | outcomes,of |
| R5522 | T3048 | T91601 | arg2Of | patients,of |
| R74118 | T3048 | T6238 | arg1Of | patients,ten |
| R51409 | T3048 | T18696 | arg1Of | patients,with |
| R40479 | T71443 | T18696 | arg2Of | COVID-19,with |
| R90019 | T71443 | T93206 | arg1Of | COVID-19,severe |
| R55615 | T7672 | T46997 | arg1Of | study,The |
| R40867 | T7672 | T83098 | arg1Of | study,showed |
| R64658 | T96870 | T83098 | arg2Of | improvement,showed |
| R66056 | T96870 | T5017 | arg1Of | improvement,clinical |
| R52864 | T96870 | T42442 | arg1Of | improvement,of |
| R70060 | T50396 | T42442 | arg2Of | patients,of |
| R51479 | T50396 | T61149 | arg1Of | patients,all |
| R50628 | T50396 | T89276 | arg1Of | patients,the |
| R30895 | T50396 | T53728 | arg1Of | patients,ten |
| R56320 | T36613 | T59179 | arg1Of | and,accompanied |
| R2541 | T50396 | T59179 | arg2Of | patients,accompanied |
| R80186 | T36613 | T83510 | arg2Of | and,by |
| R38806 | T4240 | T2183 | arg1Of | increase,an |
| R9880 | T4240 | T18383 | arg1Of | increase,in |
| R77420 | T12131 | T18383 | arg2Of | count,in |
| R60391 | T12131 | T99269 | arg1Of | count,lymphocyte |
| R95922 | T4240 | T36613 | arg1Of | increase,and |
| R85485 | T39579 | T36613 | arg2Of | decrease,and |
| R67798 | T39579 | T91622 | arg1Of | decrease,a |
| R82541 | T39579 | T72559 | arg1Of | decrease,in |
| R48725 | T31686 | T72559 | arg2Of | CRP,in |
| R83808 | T55829 | T20580 | arg1Of | turned,Following |
| R25087 | T23341 | T20580 | arg2Of | transfusion,Following |
| R66336 | T23341 | T23846 | arg1Of | transfusion,of |
| R9016 | T68740 | T23846 | arg2Of | plasma,of |
| R27767 | T68740 | T23496 | arg1Of | plasma,convalescent |
| R79010 | T55829 | T74721 | arg1Of | turned,"," |
| R49789 | T26913 | T3255 | arg1Of | patients,all |
| R98083 | T26913 | T47829 | arg1Of | patients,the |
| R36266 | T26913 | T16466 | arg1Of | patients,seven |
| R42101 | T26913 | T47643 | arg1Of | patients,who |
| R24725 | T26913 | T10299 | arg1Of | patients,were |
| R12375 | T2642 | T10299 | arg2Of | RNA,were |
| R19448 | T2642 | T19318 | arg1Of | RNA,SARS-CoV2 |
| R23710 | T2642 | T76428 | arg1Of | RNA,positive |
| R34529 | T10299 | T59448 | arg1Of | were,before |
| R60141 | T49967 | T59448 | arg2Of | transfusion,before |
| R2931 | T49967 | T2352 | arg1Of | transfusion,of |
| R3822 | T57517 | T2352 | arg2Of | plasma,of |
| R20207 | T57517 | T3020 | arg1Of | plasma,convalescent |
| R30096 | T26913 | T55829 | arg1Of | patients,turned |
| R66579 | T26456 | T55829 | arg2Of | negative,turned |
| R14919 | T26456 | T39392 | arg1Of | negative,SARS-CoV2 |
| R49718 | T26913 | T26456 | arg1Of | patients,negative |
| R70070 | T52249 | T13795 | arg1Of | There,were |
| R68506 | T35357 | T13795 | arg2Of | groups,were |
| R94657 | T35357 | T15563 | arg1Of | groups,no |
| R49835 | T35357 | T53693 | arg1Of | groups,control |
| R88768 | T35357 | T16756 | arg1Of | groups,receiving |
| R7103 | T58859 | T16756 | arg2Of | or,receiving |
| R65241 | T81904 | T53621 | arg1Of | plasma,convalescent |
| R80896 | T81904 | T11852 | arg1Of | plasma,alone |
| R48507 | T81904 | T58859 | arg1Of | plasma,or |
| R74990 | T39367 | T58859 | arg2Of | therapy,or |
| R57531 | T39367 | T35171 | arg1Of | therapy,standard |
| R26123 | T16756 | T20306 | arg1Of | receiving,without |
| R11811 | T44856 | T20306 | arg2Of | therapy,without |
| R59105 | T44856 | T63670 | arg1Of | therapy,convalescent |
| R40530 | T71428 | T15733 | arg1Of | evaluate,to |
| R29016 | T16756 | T15733 | modOf | receiving,to |
| R33735 | T64138 | T71428 | arg2Of | effect,evaluate |
| R2474 | T64138 | T29390 | arg1Of | effect,the |
| R56840 | T64138 | T54708 | arg1Of | effect,main |
| R22469 | T64138 | T21425 | arg1Of | effect,of |
| R7749 | T78861 | T21425 | arg2Of | plasma,of |
| R22133 | T78861 | T75685 | arg1Of | plasma,convalescent |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T70 | 20-26 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T71 | 87-93 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
| T72 | 230-236 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T73 | 604-610 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T74 | 651-657 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T75 | 819-825 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T76 | 839-847 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T77 | 1093-1103 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
| T78 | 1171-1177 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T79 | 1221-1224 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T80 | 1269-1275 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T81 | 1355-1361 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T82 | 1461-1467 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T55 | 56-64 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T56 | 123-131 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T57 | 334-350 | Disease | denotes | influenza A H1N1 | http://purl.obolibrary.org/obo/MONDO_0005460 |
| T58 | 366-381 | Disease | denotes | virus infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T59 | 408-413 | Disease | denotes | Ebola | http://purl.obolibrary.org/obo/MONDO_0005737 |
| T60 | 558-566 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T61 | 571-580 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T62 | 687-695 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T63 | 727-735 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T64 | 991-999 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T65 | 1211-1220 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T66 | 1283-1292 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T84 | 0-64 | Sentence | denotes | 4.1.1 Convalescent plasma from patients recovered from COVID-19 |
| T85 | 66-86 | Sentence | denotes | 4.1.1.1 Hypothesis: |
| T86 | 87-168 | Sentence | denotes | Plasma from patients recovered from COVID-19 contain antibodies against 2019-nCoV |
| T87 | 169-284 | Sentence | denotes | A look at the history of viral outbreaks offers convalescent plasma as the only remedy to avoid further fatalities. |
| T88 | 285-479 | Sentence | denotes | The most recent examples include the pandemic of influenza A H1N1 (H1N1pdm09) in virus infection 2009, the Western African Ebola virus epidemic in 2014, and the outbreak of MERS-CoV in 2015 [9]. |
| T89 | 480-616 | Sentence | denotes | Meta-analysis studies have shown a reduced risk of mortality in patients with SARS-CoV and influenza receiving convalescent plasma [10]. |
| T90 | 618-637 | Sentence | denotes | 4.1.1.2 Rationale: |
| T91 | 638-735 | Sentence | denotes | Convalescent plasma from patients recovered from COVID-19 can treat patients with severe COVID-19 |
| T92 | 736-1000 | Sentence | denotes | A pilot study [11] recently has investigated the safety and effect of convalescent plasma that contain antibody levels higher than 1:640 combined with regular anti-viral agents and standard supportive care on clinical outcomes of ten patients with severe COVID-19. |
| T93 | 1001-1132 | Sentence | denotes | The study showed clinical improvement of all the ten patients accompanied by an increase in lymphocyte count and a decrease in CRP. |
| T94 | 1133-1302 | Sentence | denotes | Following transfusion of convalescent plasma, all the seven patients who were SARS-CoV2 RNA positive before transfusion of convalescent plasma turned SARS-CoV2 negative. |
| T95 | 1303-1468 | Sentence | denotes | There were no control groups receiving convalescent plasma alone or standard therapy without convalescent therapy to evaluate the main effect of convalescent plasma. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32413736-25030060-48112969 | 612-614 | 25030060 | denotes | 10 |
| T58999 | 612-614 | 25030060 | denotes | 10 |